Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hausding

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 4, 2013
Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in agingMatthias Oelze, Swenja Kröller-Schön, Sebastian Steven, et al.
EMBO Molecular Medicine|May 4, 2011
IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway diseaseOurania Koltsida, Michael Hausding, Athanasios Stavropoulos, et al.
Basic Research in Cardiology|January 21, 2015
Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemiaSebastian Steven, Michael Hausding, Swenja Kröller-Schön, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cellsSabine Kossmann, Melanie Schwenk, Michael Hausding, et al.
Circulation|August 31, 2011
Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunctionPhilip Wenzel, Maike Knorr, Sabine Kossmann, et al.
Plos One|November 18, 2014
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityMatthias Oelze, Swenja Kröller-Schön, Philipp Welschof, et al.
Cardiovascular Research|July 31, 2012
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibitionSwenja Kröller-Schön, Maike Knorr, Michael Hausding, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Antioxidants & Redox Signaling|July 13, 2013
Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal modelsSwenja Kröller-Schön, Sebastian Steven, Sabine Kossmann, et al.
Cardiovascular Research|October 17, 2017
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db miceSebastian Steven, Mobin Dib, Michael Hausding, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|December 4, 2013
Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in agingMatthias Oelze, Swenja Kröller-Schön, Sebastian Steven, et al.
EMBO Molecular Medicine|May 4, 2011
IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway diseaseOurania Koltsida, Michael Hausding, Athanasios Stavropoulos, et al.
Basic Research in Cardiology|January 21, 2015
Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemiaSebastian Steven, Michael Hausding, Swenja Kröller-Schön, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cellsSabine Kossmann, Melanie Schwenk, Michael Hausding, et al.
Circulation|August 31, 2011
Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunctionPhilip Wenzel, Maike Knorr, Sabine Kossmann, et al.
Plos One|November 18, 2014
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityMatthias Oelze, Swenja Kröller-Schön, Philipp Welschof, et al.
Cardiovascular Research|July 31, 2012
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibitionSwenja Kröller-Schön, Maike Knorr, Michael Hausding, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Antioxidants & Redox Signaling|July 13, 2013
Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal modelsSwenja Kröller-Schön, Sebastian Steven, Sabine Kossmann, et al.
Cardiovascular Research|October 17, 2017
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db miceSebastian Steven, Mobin Dib, Michael Hausding, et al.
Pageof 4